20th IVBM
Helsinki, Finland
June 3-7, 2018
Abstracts due March 19!
Vasculata 2018
St. Louis, MO
July 23 - 26, 2018
Vascular Biology
Newport, RI
October 14-18, 2018
|
Trainee Awards
We support our trainee members in attending more than just NAVBO meetings - we have awards for the GRC, IVBM, Lymphatic Forum and World Congress on Microcirculation!
Go to http://www.navbo.org/awards/trainee-awards
|
Shop at Amazon?
Help Support NAVBO
Use this link to shop for everyone and everything
smile.amazon.com/ch/52-1917956 and Amazon will donate to NAVBO
First time? Great!!! You'll earn 1.5% for NAVBO from March 12-31!!
|
|
 |
|
|
Submission Deadlines Looming
|
Session Proposal for Vascular Biology 2019
In 2019, we will continue to incorporate "member developed" sessions for Vascular Biology, NAVBO's annual meeting. We are seeking submissions in any area of research that members consider topical as well as ideas for the Vascular Therapeutics session. The featured workshops at Vascular Biology 2019 are Developmental Vascular Biology and Genetics and Vascular Matrix Biology and Bioengineering. Please note the deadline is fast approaching - April 2, 2018.
See the web site for more details
.
|
Seeking NAVBO Councilors
If you are a regular NAVBO member in good standing
(dues paid through December 31, 2018) you are eligible to run for Council. If you would like to take an active leadership role in this society and help guide our mission, please take the time to apply for a position on the NAVBO Council. Six applicants will be chosen for the ballot. Deadline to submit is March 31, 2018. See
http://www.navbo.org/membership/call-for-council-nominations
. You will need to log in.
|
Next Webinar is April 5
- featuring Jessica Wagenseil of Washington University in St. Louis
|
|
IVBM - Now Accepting Late-Breaking Abstracts
|
Submit your late-breaking abstract through May 7
|
|
Register for Vasculata and Vascular Biology
|
Register for Vascular Biology and Vasculata
Registration is now open for our annual meeting,
Vascular Biology (October 14-18 in Newport, RI). Go to
www.navbo.org/vb2018
You can also register now for
Vasculata 2018 (July 23-26, St. Louis, MO). Go to
www.navbo.org/vasculata.
Remember workshops fill up quickly, so register soon!
You can also
submit an abstract for either meeting. Go to the appropriate meeting web site.
|
|
Vascular Calcification - Call for Papers
|
NAVBO Research Topic on Vascular
Calcification
NAVBO has joined with Frontiers, publishers of
Frontiers In Cardiovascular Medicine,and co-editors
Dwight Towler, UT Southwestern Medical Center and
Yabing Chen, University of Alabama, to assemble a collection of papers in the research topic of Vascular Calcification.
|
Stand United in Supporting Science
|
The Lab of Dr. Stryder Meadows
|
|
Spotlight on Trainees
(from the March 8 issue)
|
Who benefits from-and pays for-the work of creating an equitable and inclusive work environment?
Expecting graduate students to shoulder the burden of efforts that honor and celebrate diversity, benefiting the broader university community-without compensation or accountability-is by its nature exploitative, argues Prabhdeep Kehal, a doctoral student in sociology at Brown University. Writing in
Inside Higher Ed
, Kehal notes that "[t]hroughout my postsecondary career, much of my time has been dedicated to supporting diversity and inclusion initiatives. I volunteered this labor as if these institutions were entitled to my time. Very rarely was I asked to engage, because the assumption was that I would engage. After experiencing years of slow progress, I came to see more clearly an immense gap between an institution's intention for inclusion and their investment in it." The author's experience, and that of others cited, has left a sense of frustration alongside their commitment to the value of diversity and inclusion in the academy.
|
|
Lessons Learned
(from the March 8 issue)
|
Staying Ahead of the Game
Greetings from New Orleans! My name is Stryder Meadows and I am an Assistant Professor at Tulane University. In 2014, I dove head first into the most challenging undertaking of my life. I uprooted my family and started my own research lab in a new state. Reflecting on the past 3 years, I would like to think I've had some professional successes while minimizing the hiccups along the way. I'm happy to have the opportunity to share my thoughts and opinions about my journey, and hope that my experiences prove useful to future independent investigators. We are all somewhat thrown into this position with no road map for establishing a thriving research program, so be proactive in seeking advice and stay ahead of the game. . .
Read this piece in its entirety along with other lessons learned.
If you would like to share your lessons learned as you moved into your role as an independent investigator, send your submission to
editor@navbo.org
.
|
Welcome to our New Members:
Fabeha Fazal, University of Rochester
Daniyal Jafree, University College London
Xiaolei Liu, Northwestern University
Bria Macklin, Johns Hopkins University
Corinne Nielsen, Ohio University
Chanele Polenz, University of Toronto
Bartosz Proniewski, Jagiellonian University
Brian Raftrey, Stanford University
Sarvenaz Sarabipour, Johns Hopkins University
Marta Sojak, Jagiellonian Centre for Experimental Therapeutics
Joanna Suraj, Jagiellonian University
Bo Tao, Yale University
Ann-Cathrin Werner, LMU Munich
Pengchun Yu, Yale University School of Medicine
Wenping Zhou, Yale University
|
|
Recent Publications by NAVBO Members
|
| Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice
American Journal of Physiology - Heart and Circulatory Physiology
Calcific aortic vasculopathy correlates with bone loss in osteoporosis in an age-independent manner. Prior work suggests that teriparatide, the bone anabolic treatment for postmenopausal osteoporosis, may inhibit onset of aortic calcification. Read more Whole-Mount Adult Ear Skin Imaging Reveals Defective Neuro-Vascular Branching Morphogenesis in Obese and Type 2 Diabetic Mouse Models
Scientific Reports
Obesity and type 2 diabetes are frequently associated with peripheral neuropathy. Though there are multiple methods for diagnosis and analysis of morphological changes of peripheral nerves and blood vessels, three-dimensional high-resolution imaging is necessary to appreciate the pathogenesis with an anatomically recognizable branching morphogenesis and patterning. Read more Postnatal development of lymphatic vasculature in the brain meninges
Developmental Dynamics
BACKGROUND: Traditionally, the central nervous system (CNS) has been viewed as an immune-privileged environment with no lymphatic vessels. Read more Peripheral post-ischemic vascular repair is impaired in a murine model of Alzheimer's disease
Angiogenesis
The pathophysiology of sporadic Alzheimer's disease (AD) remains uncertain. Along with brain amyloid-β (Aβ) deposits and neurofibrillary tangles, cerebrovascular dysfunction is increasingly recognized as fundamental to the pathogenesis of AD. Read more Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress
International Journal of Molecular Sciences
Although chemotherapeutics can be highly effective at targeting malignancies, their ability to trigger cardiovascular morbidity is clinically significant. Read more Neutrophils recruited through high endothelial venules of the lymph nodes via PNAd intercept disseminating Staphylococcus aureus
PNAS
Staphylococcus aureus is a skin- and respiratory tract-colonizing bacterium and is the leading cause of community-acquired skin infections. Read more Visualizing the function and fate of neutrophils in sterile injury and repair
Science
Neutrophils have been implicated as harmful cells in a variety of inappropriate inflammatory conditions where they injure the host, leading to the death of the neutrophils and their subsequent phagocytosis by monocytes and macrophages. Read more Pericyte ALK5/TIMP3 axis in pericytes contributes to endothelial morphogenesis in the developing brain
Developmental Cell
he murine embryonic blood-brain barrier (BBB) consists of endothelial cells (ECs), pericytes (PCs), and basement membrane. Read more |
Industry News (from the March 8 issue)
|
Experimental Reproducibility in Crisis
There is a reproducibility crisis occurring in the life sciences that impacts all researchers, influencing the collection, analysis, and interpretation of their data. Recent surveys have shown that more than half of researchers struggle to reproduce not only the results of their fellow scientists, but their own experimental data as well. To help scientists wrestle with this thorny issue, Science magazine is hosting a webinar on Wednesday March 14, 2018. Viewers will learn how irreproducible or questionable data can result in time-consuming, costly repetition of studies and, in some cases, misinterpreted or incorrect conclusions. Participants include John Ioannidis, M.D., D.Sc., from Stanford University and Gregor Witte, Ph.D., from Ludwig Maximillian Universität in Munich.
Updated Parent Program Announcements for NIH Fellowships Released
Welcome tidings for pre- and post-doctoral trainees in search of fellowship support: the NIH has issued 2018 program announcements for their family of Ruth L. Kirschstein National Research Service Awards (NRSAs). Opportunities include sponsorship for Individual
Predoctoral Fellows to Promote Diversity in Health-Related Research (F31), Individual Fellowships for Students at Institutions with NIH-Funded Institutional
Predoctoral Dual-Degree Training Programs (F30),
Individual Postdoctoral Fellowships (F32), and
Individual Predoctoral Fellowships (F31). This family of programs is long-standing, and its components have been reliably re-issued at 2-3 year intervals; nevertheless, it is reassuring for trainees-and their mentors-to see the current crop emerge.
Speaking of NIH funding...it translates!
From STAT
A study recently published in PNAS by researchers at Bentley University documents the importance of federal support for basic research: NIH-funded studies contributed to the science that underlies every one of the 210 new drugs approved by the FDA between 2010 and 2016. The study, led by Dr. Fred Ledley of Bentley's Center for Integration of Science and Industry, is novel in its examination of the links, both direct and indirect, between NIH sponsorship and the advent of FDA-approved drugs. The authors conclude with a strong case for continued federal funding of basic science - which some view as under threat by the current administration. Of the 210 approved agents, 84 were considered "first-in-class," that is, treating disease through novel mechanisms or molecular targets.
|
|
|
